Quarterly Results

JUBILANT PHARMOVA LTD.

NSE : JUBLPHARMABSE : 530019ISIN CODE : INE700A01033Industry : Pharmaceuticals & DrugsHouse : Jubilant Bhartia
BSE568.50-3.1 (-0.54 %)
PREV CLOSE ( ) 571.60
OPEN PRICE ( ) 573.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9624
TODAY'S LOW / HIGH ( )563.05 575.75
52 WK LOW / HIGH ( )268.8 627
NSE569.90-2.25 (-0.39 %)
PREV CLOSE( ) 572.15
OPEN PRICE ( ) 572.15
BID PRICE (QTY) 569.90 (104)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 214984
TODAY'S LOW / HIGH( ) 562.70 578.35
52 WK LOW / HIGH ( )268.9 627.45
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
16771
16803
15869
16780
Total Expenditure
14591
14385
14173
14587.8
PBIDT (Excl OI)
2180
2418
1696
2192.2
Other Income
358
99
86
44.5
Operating Profit
2538
2517
1782
2236.7
Interest
713
661
619
555.6
Exceptional Items
NA
NA
NA
NA
PBDT
1825
1856
1163
1681.1
Depreciation
946
966
897
2712.3
Profit Before Tax
879
890
266
-1031.2
Tax
346
359
192
141
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
533
531
74
-1172.2
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
533
531
74
-1172.2
Minority Interest
4
4
4
26.7
Shares of Associates
131
90
-14
167.1
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
668
625
64
-978.4
Equity Capital
158
158
158
159.1
Face Value (IN RS)
1
1
1
1
Reserves
NA
NA
NA
NA
Calculated EPS
4.22
3.95
0.40
-6.14
Calculated EPS (Annualised)
16.91
15.82
1.62
-24.59
No of Public Share Holdings
78564083
78564083
78564083
78564083
% of Public Share Holdings
49.32
49.32
49.32
49.32
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
12.99
14.39
10.68
13.06
PBIDTM%
15.13
14.97
11.22
13.32
PBDTM%
10.88
11.04
7.32
10.01
PBTM%
5.24
5.29
1.67
-6.14
PATM%
3.17
3.16
0.46
-6.98
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.